Press Release Archive

04.03.2009

Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Human Rights In Clinical Research

04.02.2009

Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas

04.01.2009

Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue

03.30.2009

Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix(®) (Varenicline) Compared With Placebo

03.30.2009

Intensive Lipitor Therapy Provided Sustained Risk Reduction Of Cardiovascular Events In Older Patients With Heart Disease

03.24.2009

Pfizer Announces Completion of $13.5 Billion Debt Offering

03.22.2009

Pfizer’s Oncology Business Unit Appoints Senior Executive to Head U.S. Region

03.19.2009

Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China

03.18.2009

Pfizer-Sponsored Prescription Savings Program - Together Rx Access® - Expands Eligibility Criteria in Response to Challenging Economic Times

03.16.2009

U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor

03.12.2009

Wide-Reaching Global Survey Reveals Majority of Women Living with Metastatic Breast Cancer Desire Increased Public Attention

03.09.2009

Pfizer Invites Public to View and Listen to Webcast of Investor Breakfast at Healthcare Conference